Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. news
  3. patients in accessing
Show results for

Refine by
Date

  • This Year
  • Older

Patients In Accessing Articles & Analysis

238 news found

SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

SOPHiA Genetics Achieves ISO 27017 and ISO 27018 Certifications

These internationally recognized standards, developed and published by the world’s most recognized standards organization for information security management systems, underscore the Company’s commitment to maintaining the highest standards of security and data protection for its customers and the patients they serve. SOPHiA GENETICS has consistently prioritized the ...

BySOPHiA Genetics


Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Protheragen-ING Announces Lyophilized Flash-release Formulations Development Capabilities

Overall, the freeze-dried rapid-release formulations by Protheragen-ING offer several benefits: l They enhance the drug’s stability, prolong its shelf life, and boost its bioavailability. l These formulations allow the medication to be absorbed into the body at a regulated release rate, leading to improved therapeutic outcomes. l They make drug therapy more accessible for ...

ByProtheragen-ING


Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

Tempus Announces Expansion of Collaboration with AstraZeneca to Leverage Tempus Next to Support Guideline-directed Biomarker Testing in NSCLC

EGFR is a biomarker that presents in some patients with NSCLC and that has specific targeted therapies associated with it. ...

ByTempus


Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the Treatment of Attention Deficit Hyperactivity Disorder

Tris Pharma Partners with Perigon Pharmacy 360 to Enhance Access to DYANAVEL® XR Tablets for the Treatment of Attention Deficit Hyperactivity Disorder

The program is available across the United States, enabling nationwide access to DYANAVEL XR extended-release tablets. Patients and physicians wishing to access the DYANAVEL Delivered program can learn more at www.dyanavel.com/delivered. “This partnership underscores our continued commitment to ensuring patients have ...

ByTris Pharma, Inc.


Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc

This is a testament to each member’s commitment to Tevogen’s patient-centric approach of merging affordability with advanced science — a blueprint for sustainable success in the upcoming era of medicine.” Tevogen Bio is a clinical-stage specialty immunotherapy company harnessing one of nature’s most powerful immunological weapons, CD8+ cytotoxic T ...

ByTevogen Bio


Press release: High quality, cost effective surgical retractor is welcomed by leading US hospital group

Press release: High quality, cost effective surgical retractor is welcomed by leading US hospital group

JUNE Medical is delighted to announce a new agreement with a major US hospital group to supply the award-winning Galaxy II® self-retaining surgical retractors to over 1,600 hospitals in the US, commencing April 15, 2023. This game-changing device radically improves the safety and ease of surgical retraction for both patients and medical staff; its ergonomic design transforms the way in which ...

ByJUNE Medical USA Inc


Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost

Frontier Biotech opens a new manufacture facility in Chengdu - Aikening, a novel long-acting HIV medicine, receives a production capability boost

The completion of the facility will accelerate patient access to the new drug, and improve the prevention and and treatment of HIV infection in the region. ...

ByFrontier Biotechnologies Inc.


Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDU (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in ER+, HER2- Advanced or Metastatic Breast Cancer

Stemline is committed to helping patients access ORSERDU and will be offering services to overcome access barriers. ...

ByThe Menarini Group


CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

CHMP recommends Bayer’s darolutamide for the treatment of metastatic hormone-sensitive prostate cancer

“With darolutamide’s unprecedented survival data and minimal disruption to patients´ daily living across both mHSPC and high risk nmCRPC, following regulatory approval, we will be working to ensure that as many patients as possible benefit from darolutamide. ...

ByBayer AG


Iterative Scopes Partners with One GI to Advance Gastrointestinal Care Through Artificial Intelligence

Iterative Scopes Partners with One GI to Advance Gastrointestinal Care Through Artificial Intelligence

By initiating the collaboration at Gastro One, the organizations are taking initial steps to develop a hub and spoke recruitment model for One GI®, which will democratize access to the novel IBD therapeutics for all patients, regardless of where they receive care. ...

ByIterative Health, Inc.


LifeScan’s Response to the Invasion of Ukraine

LifeScan’s Response to the Invasion of Ukraine

As part of our longstanding commitment to supporting numerous relief efforts around the world, LifeScan is working with the non-profit humanitarian organization, Direct Relief, to respond to the urgent need to supply much-needed blood glucose testing supplies to the many Ukrainians now without access to critical health products. We have also taken steps to help ensure continued ...

ByLifeScan


xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

xCures partners with RenovoRx to assist patients in accessing RenovoRx’s TIGeR-PaC study

Through this collaboration, xCures will help eligible pancreatic cancer patients access a Phase III clinical study entitled, Targeted Intra-arterial Gemcitabine vs. ...

ByxCures


Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

Iterative Health Partners with Gastro Health to Accelerate Clinical Research in Gastroenterology Through Artificial Intelligence

“Our shared mission with Iterative Health to democratize access to the highest quality GI care has opened the door for us to utilize AIR in our practices,” said Joseph Garcia, CEO of Gastro Health. ...

ByIterative Health, Inc.


Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List

Digital Diagnostics Named to the 2022 CB Insights’ Digital Health 150 List

“This increasingly global cohort, representing more than 18 countries across five continents, is not only driving better patient outcomes, but making healthcare more accessible. We are excited to follow the meaningful impact and continued success of this year’s ...

ByDigital Diagnostics Inc.


Simeox device is now available in Canada!

Simeox device is now available in Canada!

Proud to partner with Novus Medical to help respiratory clinicians improve the life of their patients through access to Simeox. The Simeox device is an efficient and comfortable therapy for distal mucus clearance – for patients suffering from chronic lung conditions associated with chest congestion, such as bronchiectasis, cystic fibrosis, ...

ByPhysioAssist


Finally, cancer patients have real-time access to their medical records

Finally, cancer patients have real-time access to their medical records

Last month, the 21st Century Cures Act forced healthcare organizations to provide patients quick and easy access to their health records in a digital format. In response to the news, xCures is happy to announce that patients using their platform, can now automatically retrieve their medical records from the institutions where they received ...

ByxCures


Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022

Galapagos presents roadmap for pipeline and commercial growth at its R&D Day 2022

Our core mission in the field is to broaden patient access and improve clinical outcomes by bringing best-in-class medicines to patients. ...

ByGalapagos NV


electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC

electroCore, Inc. Announces Distribution Agreement with Joerns Healthcare, LLC

“Assisting in the distribution and billing of electroCore’s Sapphire nVNS therapy will make it easier for managed care and other providers to ensure their patients have access to the best available therapies when and where they need them.” “We are excited to be working with Joerns as we expand patient ...

ByelectroCore, Inc.


OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology

OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology

“Our contract with Vizient enables increased access through negotiated pricing to OSSIOfiber technology for thousands of U.S. hospitals and surgery centers,” said OSSIO Chief Commercial and Operating Officer Brennan Marilla. “Our strong and biointegrative fixation products provide patients durable fixation and natural healing, which addresses ...

ByOSSIO Inc


Berkshire and Surrey Pathology Services & ONCODNA announce formation of a national tissue collection centre that will facilitate private NGS testing across the UK

Berkshire and Surrey Pathology Services & ONCODNA announce formation of a national tissue collection centre that will facilitate private NGS testing across the UK

DR CHENG BOON, ONCOLOGIST IN THE PRIVATE SECTOR AND THE NHS AS WELL AS ACTING AS ONCODNA UK MEDIAL DIRECTOR COMMENTED: “In my view, this is an important first step in a collaboration that will make it much easier for public and privately practising oncologists to access biopsy tissue and request ONCODEEP* for the purpose of routine next generation sequencing. ...

ByOncoDNA S.A.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT